← All organizations

Akebia Therapeutics

For profitContributed to NMEWebsite ↗

Also known as: AKEBIA | Akebia Therapeutics | Akebia Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Oct 23, 2025

Timeline

2000s

Jul 1, 2007
Akebia Therapeutics— Founded

2010s

Jun 29, 2018
Keryx— Acquired

2020s

Mar 27, 2024
vadadustat— NDA Organization

Drugs by trial phase (31 distinct, 64 trials)

Phase 4 (0 own, 2 via acquisition)

Phase 3 (3 own, 2 via acquisition)

Phase 2 (1 own, 5 via acquisition)

Phase 1 (15 own, 3 via acquisition)

Indications

Studied for

Marketed drugs (1)

vadadustat

Subsidiaries (1 direct, 2 total across the full acquisition tree)

Recent trials (50)

NCT07086755CollaboratorPhase 2/Phase 3Oct 23, 2025
NCT06901505Lead sponsorPhase 3Jul 24, 2025
NCT06520826CollaboratorPhase 3Oct 1, 2024
NCT05082584Study directorPhase 3Nov 30, 2021
NCT05082571Lead sponsorPhase 3Nov 30, 2021
NCT05082584Lead sponsorPhase 3Nov 30, 2021
NCT05085275CollaboratorPhase 3Nov 30, 2021
NCT05082571Study directorPhase 3Nov 30, 2021
NCT04707768Study directorPhase 3Jul 21, 2021
NCT04707768Lead sponsorPhase 3Jul 21, 2021
NCT04922645CollaboratorPhase 4Jun 29, 2021
NCT04478071CollaboratorPhase 2Aug 22, 2020
NCT04313153Lead sponsorPhase 3Apr 30, 2020
NCT04299633Lead sponsorPhase 1Mar 31, 2020
NCT03992066Lead sponsorPhase 1May 28, 2019

Details

Founded: Cambridge, MA, US Jul 1, 2007
First NDA: Mar 27, 2024
Last known activity: Oct 23, 2025